Are Blood Tests for Alzheimer Disease Ready for Prime Time?

JAMA. 2024 Oct 15;332(15):1240-1241. doi: 10.1001/jama.2024.12814.

Authors

Stephen Salloway¹, Christopher Rowe^{2

3

4}, Jeffrey M Burns⁵

Affiliations

¹ Departments of Psychiatry and Neurology, Warren Alpert Medical School, Brown University, Providence, Rhode Island.
² Department of Molecular Imaging, Austin Health, Melbourne, Australia.
³ Florey Institute of Neuroscience and Mental Health, Melbourne, Australia.
⁴ Australian Dementia Network, University of Melbourne, Melbourne, Australia.
⁵ Alzheimer's Disease Research Center, University of Kansas Medical Center, Lawrence.

PMID: 39068544
DOI: 10.1001/jama.2024.12814

No abstract available

Publication types

Editorial
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Alzheimer Disease* / blood
Alzheimer Disease* / diagnosis
Amyloid beta-Peptides / blood
Amyloid beta-Peptides / isolation & purification
Biomarkers* / blood
Humans
Mass Spectrometry
tau Proteins / blood
tau Proteins / isolation & purification

Substances

Amyloid beta-Peptides
Biomarkers
tau Proteins